An overview of prostate cancer: diagnosis and treatment
Strief, D.M.
Urologic Nursing 27(6): 475-479; Quiz 480
2007
ISSN/ISBN: 1053-816X PMID: 18217529 Document Number: 609335
The state of the science for prostate cancer is presented including a review of current screening, diagnosis, and treatment options for localized prostate cancer. Educational resource options appropriate for this population are outlined.
Document emailed within 1 workday
Related Documents
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420Bissada, N.K. 2000: Prostate cancer: an overview Journal of the South Carolina Medical Association 96(2): 52
Fuchsjäger, M.; Akin, O.; Shukla-Dave, A.; Pucar, D.; Hricak, H. 2009: The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer Clinical Advances in Hematology and Oncology: H&o 7(3): 193-202
Lopez, J.G.; Perrin, P. 1999: Cancer of the prostate. Diagnosis, prognosis, principles of treatment La Revue du Praticien 49(3): 297-301
Baltogiannis, D.; Giannakopoulos, X.; Charalabopoulos, K.; Sofikitis, N. 2004: Monotherapy in advanced prostate cancer: an overview Experimental Oncology 26(3): 185-191
Viollet, G.; Robin, M.; Colombeau, P.; Ciblac, G. 1977: Apropos of diagnosis, prognosis and hormonal treatment of cancer of the prostate Journal d'Urologie et de Nephrologie 83(10-11): 896-900
Teishima, J.; Matsubara, A. 2016: Mechanism of development and progression in prostate cancer: Overview Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 80-86
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Polednak, A.P. 1998: Prostate cancer treatment in black and white men: the need to consider both stage at diagnosis and socioeconomic status Journal of the National Medical Association 90(2): 101-104
Chiaverini, L.C.; Fulton, J.P.; Buechner, J.S. 2006: Stage at diagnosis and first course of treatment for prostate cancer in Rhode Island, 1990-2003 Medicine and Health Rhode Island 89(2): 81-82
De la Taille, A.; Houlgatte, A.; Houdelette, P.; Berlizot, P.; Ramirez, J.; Ricordel, I. 1997: Value of free/total prostate specific antigen in the early diagnosis of prostate cancer (study of 105 patients) Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(2): 240-245
Topuzov, M.E. 2007: Role of density of prostate-specific antigen transitory zone in early diagnosis of prostate cancer Voprosy Onkologii 53(3): 295-297
Jung, P.; Wolff, J.M.; Mattelaer, P.; Jakse, G. 1996: Prostate specific antigen in the diagnosis and staging of prostate cancer Acta Urologica Belgica 64(3): 1-6
Rigaud, J.ér.ôm.; Bouchot, O. 2003: Prostate specific antigen and diagnosis of prostate cancer La Revue du Praticien 53(20): 2229-2236
Qu, H.-W.; Liu, H.; Cui, Z.-L.; Jin, X.-B.; Zhao, Y.; Wang, M.-W.; Song, W.; Zhang, X.-J. 2016: Focusing on MRI-suspected lesions in targeted transrectal prostate biopsy guided by MRI-TRUS fusion imaging for the diagnosis of prostate cancer Zhonghua Nan Ke Xue 22(9): 782-786
Solé Balcells, F.J. 1989: Early diagnosis of cancer of the prostate. Value of systemic screening and of diagnosis in incidental cancer (stage A) Archivos Espanoles de Urologia 42(Suppl 2): 131-138
Cerović, S.; Dimitrijević, J.; Milović, N.; Ajdinović, B.; Knezević-Usaj, S.; Popović, L.; Brajusković, G. 2002: Prostate-specific antigen in the diagnosis and treatment of carcinoma of the prostate Vojnosanitetski Pregled 59(6 Suppl): 53-57
Horiguchi, A.; Hatakeyama, N.; Ikeuchi, K. 1999: Dynamics of prostate-specific antigen as prognostic factors in endocrine treatment for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 45(1): 31-35
Habib, F.K.; Ross, M.; Bayne, C.W. 1999: Factors controlling the expression of 5alpha-reductase in human prostate: A possible new approach for the treatment of prostate cancer European Urology 35(5-6): 439-442
Zissimopoulos, A.; Stellos, K.; Matthaios, D.; Petrakis, G.; Parmenopoulou, V.; Babatsikou, F.; Matthaiou, E.; Theodosiadou, E.; Hountis, P.; Koutis, C. 2009: Type i collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy Journal of Buon: Official Journal of the Balkan Union of Oncology 14(3): 463-472